Newsfeeds Archive - Page 8 of 8

1 minute read

Here’s How Much You Would Have Made Owning NICE Stock In The Last 5 Years

August 19, 11:03 AM

NICE (NASDAQ:NICE) has outperformed the market over the past 5 years by 11.47% on an annualized basis producing an average annual return of 23.02%. Currently, NICE has a market capitalization of $13.77 billion.

NICE

1 minute read

Analyst Ratings

Where NICE Stands With Analysts

By Benzinga Insights

August 19, 11:02 AM

Within the last quarter, NICE (NASDAQ:NICE) has observed the following analyst ratings:

NICE

1 minute read

RBC Capital Maintains Outperform on NICE, Raises Price Target to $265

By Benzinga Newsdesk

August 19, 7:14 AM

RBC Capital analyst Rishi Jaluria maintains NICE (NASDAQ:NICE) with a Outperform and raises the price target from $240 to $265.

NICE

1 minute read

NICE Tops Q2 Backed By Growing Cloud Business At Scale; Boosts FY22 Guidance

By Anusuya Lahiri

August 18, 7:14 AM

NICE Ltd (NASDAQ:NICE) reported second-quarter FY22 non-GAAP revenue growth of 15.6% year on year to $530.6 million, beating the consensus of…

NICE

1 minute read

Earnings

Recap: NICE Q2 Earnings

By Benzinga Insights

August 18, 5:59 AM

NICE (NASDAQ:NICE) reported its Q2 earnings results on Thursday, August 18, 2022 at 05:30 AM. Here's what investors need to know about the announcement.

NICE

3 minute read

Earnings

Earnings Scheduled For August 18, 2022

By Benzinga Insights

August 18, 5:00 AM

Companies Reporting Before The Bell • Calliditas Therapeutics (NASDAQ:CALT) is expected to report quarterly loss at $1.00 per share on revenue of $7.50 million.

ADXN

2 minute read

Analyst Ratings

Barclays Maintains Overweight Rating for NICE: Here’s What You Need To Know

By Benzinga Insights

July 26, 12:26 PM

Barclays has decided to maintain its Overweight rating of NICE (NASDAQ:NICE) and lower its price target from $356.00 to $283.00. Shares of NICE are trading down 2.64% over the last 24 hours, at $201.53 per share. A move to $283.00 would account for a 40.43% increase from the current share price.

NICE